Nemolizumab-Ilto 30 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 30 mg/mL
Reference Brands: Nemluvio (USA)
Category: Derma Drugs
Nemolizumab-Ilto is a Derma Drugs product available as Injection in strengths 30 mg/mL. It corresponds to the reference brand Nemluvio (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Nemolizumab-ilto injection is a biologic medicine used for the treatment of moderate to severe inflammatory skin conditions. It is administered alone or in combination with other treatments such as topical corticosteroids or calcineurin inhibitors when symptoms are not adequately controlled with topical therapy alone. This targeted treatment option is especially beneficial for patients who continue to experience persistent symptoms despite standard topical management.
Nemolizumab-ilto is also indicated for the treatment of prurigo nodularis, a chronic skin disorder characterized by intense itching and nodular skin lesions. By targeting specific immune pathways involved in itch and inflammation, nemolizumab-ilto helps reduce pruritus and improve skin condition. Its mechanism of action addresses the underlying causes of itch and inflammation rather than only providing symptomatic relief.
Nemolizumab-Ilto — third party manufacturing & bulk supply
Nemolizumab-Ilto 30 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Nemolizumab-Ilto is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Nemolizumab-Ilto listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Nemolizumab-Ilto →Frequently Asked Questions
Nemolizumab-ilto is used for the treatment of prurigo nodularis in adults.
Nemolizumab-ilto is a recombinant humanized monoclonal antibody produced using biotechnology and genetic engineering techniques.
The trade name of nemolizumab-ilto is Nemluvio.
Nemluvio is developed and marketed by Galderma.
The generic name is nemolizumab-ilto.
The brand name is Nemluvio.
Nemolizumab-ilto is manufactured in specialized biologics manufacturing facilities, primarily in the United States and Europe, depending on the supply region.
Related Products
Sofpironium Bromide
Strength:
5%, 12.45%
Form: Topical Gel
Reference Brands: ECCLOCK, Sofdra
View DetailsSarecycline
Strength:
60 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Seysara (USA)
View DetailsAfamelanotide
Strength:
16 mg
Form: Subcutaneous implant
Reference Brands: Scenesse (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers